share_log
Reuters ·  Apr 25 09:45
Biomarin Pharmaceutical Shares Down 8.1% After Q1 Rev Miss
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment